You have 9 free searches left this month | for more free features.

gemcitabine

Showing 26 - 50 of 1,157

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Breast Tumors Trial in Charlottesville (drug, device, other)

Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Gemcitabine
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
May 17, 2022

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Pancreas Cancer Trial in Houston (Gemcitabine, Nab paclitaxel, IM156)

Not yet recruiting
  • Pancreas Cancer
  • Gemcitabine
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 15, 2022

Pancreatic Cancer Trial (Adavosertib, Gemcitabine)

Withdrawn
  • Pancreatic Cancer
  • (no location specified)
Jun 10, 2022

Pancreatic Cancer Trial in Meldola, Ravenna (Losartan, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • Meldola, Forlì, Italy
  • +1 more
May 12, 2023

Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 17, 2022

Locally Advanced Pancreatic Cancer Trial in Guangzhou (Sulfatinib, Serplulimab, Albumin-paclitaxel)

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Aug 10, 2023

Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

Recruiting
  • Advanced Biliary Tract Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022

Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

Not yet recruiting
  • Borderline Resectable Carcinoma
  • Biliary Tract Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +5 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 16, 2022

Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cairo, Egypt
    Mohamed Fawzy Salman
Nov 19, 2022

Nasopharyngeal Carcinoma, Recurrent or Metastatic Trial in Beijing (KL-A167, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 23, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Woodville South, Melbourne, Subiaco (CEND-1, Nab-paclitaxel,

Completed
  • Pancreatic Cancer
  • Pancreatic Ductal Adenocarcinoma
  • Woodville South, South Australia, Australia
  • +2 more
Oct 26, 2022

Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)

Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022

Locally Advanced Pancreatic Cancer Trial in Washington, Baltimore (Gemcitabine, Hypofractionated Ablative Proton Therapy)

Recruiting
  • Locally Advanced Pancreatic Cancer
  • Gemcitabine
  • Hypofractionated Ablative Proton Therapy
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022

Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)

Active, not recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 8, 2022

Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fairway, Kansas
    Kansas University Cancer center
Nov 2, 2022

Pancreatic Adenocarcinoma, Metastatic Trial in Spain, United States (Nab-paclitaxel, Gemcitabine, VCN-01)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Metastatic
  • New York, New York
  • +7 more
Jan 3, 2023

Small Cell Lung Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Winston-Salem (Gemcitabine,

Completed
  • Small Cell Lung Carcinoma
  • +3 more
  • Gemcitabine
  • Nivolumab
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Sep 6, 2022

LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)

Suspended
  • LMS - Leiomyosarcoma
  • Uterine Leiomyosarcoma
  • Gemcitabine
  • +5 more
  • Stanford, California
    Stanford University
Oct 24, 2022

Triple Negative Breast Cancer Trial in Shanghai (Gemcitabine, Cisplatin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Shanghai, Shanghai, China
    Cancer Hospital/ Institute, Fudan University
Jul 19, 2022

Soft Tissue Sarcoma Trial in Switzerland (Nab-Paclitaxel, gemcitabine)

Terminated
  • Soft Tissue Sarcoma
  • Basel, Switzerland
  • +7 more
Sep 27, 2022

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Pancreatic Tumors Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Neoplasms
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 10, 2022

Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

Not yet recruiting
  • Serous Ovarian Cancer
  • Advanced Ovarian Cancer
  • (no location specified)
Sep 20, 2023